This infographic highlights the key advantages of CHO cells and the technologies that are pushing the boundaries of cell ...

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024Up to $7.5 ...

Q4 2024 Earnings Call Transcript March 26, 2025 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $ ...

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024Up to $7.5 million in grants awarded from CEPI and Gates Foundation intended to acceler ...

A recent WHO-led study published in Vaccine provides updated estimates on the global production capacity of influenza ...

Ping Rawson; CFO; Dyadic International Inc. Mark Emalfarb; President, Chief Executive Officer, Director; Dyadic International Inc. Joseph Hazelton; Chief Operating O ...

Good evening and welcome to Dyadic International's Year-End 2024 Conference Call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, there will be a brief ...

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy ...

This study provides a potentially useful investigation into the positive role of BDNF/TrkB signaling in implanted dental pulp stem cells to enhance dentin regeneration in the context of dental caries.

Researchers from the J. Craig Venter Institute (JCVI), the Friedrich-Loeffler-Institut (FLI), and the International Livestock ...

Because of the ease and efficiency of production and purification of LT-proteins and the simplicity of attaching them to freshly isolated tumor cells, this approach may be used in cellular ...

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk biotechnology, today announced a groundbreaking ...